A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group.

@article{Eigen1995AMS,
  title={A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group.},
  author={Howard Eigen and Beryl J. Rosenstein and Suzanne Fitzsimmons and Daniel V Schidlow},
  journal={The Journal of pediatrics},
  year={1995},
  volume={126 4},
  pages={515-23}
}
The purpose of this study was to evaluate the efficacy and safety of alternate-day prednisone therapy in treating patients with mild-to-moderate cystic fibrosis during a 4-year period. In 15 North American cystic fibrosis centers, we screened 320 patients and enrolled 285 patients from April 1986 to December 1987. Patients were randomly assigned to take… CONTINUE READING